POIA
AZN icon

Pin Oak Investment Advisors’s AstraZeneca AZN Stock Holding History

Pin Oak Investment Advisors’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$22K Buy
114
+11
+11% +$2.07K 0.02% 300
2026
Q1 		$20K Buy
+103
New +$19.9K 0.01% 308
2025
Q4 		– Sell
-38
Closed -$5.75K – 496
2025
Q3 		$5.75K Sell
38
-39
-51% -$5.9K ﹤0.01% 417
2025
Q2 		$11K Hold
77
– – 0.01% 320
2025
Q1 		$11K Buy
77
+37
+93% +$5.35K 0.01% 315
2024
Q4 		$6K Hold
40
– – 0.01% 370
2024
Q3 		$6K Hold
40
– – 0.01% 369
2024
Q2 		$6K Sell
40
-185
-82% -$27.8K 0.01% 363
2024
Q1 		$30K Hold
225
– – 0.03% 222
2023
Q4 		$30K Buy
225
+185
+463% +$24.1K 0.03% 218
2023
Q3 		$5K Hold
40
– – 0.01% 371
2023
Q2 		$6K Buy
+40
New +$5.88K 0.01% 351
2020
Q4 		– Sell
-50
Closed -$5K – 417
2020
Q3 		$5K Buy
+50
New +$5.56K ﹤0.01% 350
2020
Q1 		– Sell
-140
Closed -$14K – 401
2019
Q4 		$14K Hold
140
– – 0.01% 289
2019
Q3 		$12K Hold
140
– – 0.01% 306
2019
Q2 		$12K Buy
+140
New +$11K 0.01% 327
2018
Q4 		– Sell
-155
Closed -$12K – 429
2018
Q3 		$12K Sell
155
-102
-40% -$7.71K 0.01% 300
2018
Q2 		$18K Sell
257
-46
-15% -$3.31K 0.01% 275
2018
Q1 		$21K Sell
303
-48
-14% -$3.33K 0.02% 263
2017
Q4 		$24K Buy
+351
New +$23.7K 0.02% 259

Other funds holding AZN

EP
Evelyn Partners London $46.9B AUM
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Pin Oak Investment Advisors's AZN Position: Q2 2026 in Review

Pin Oak Investment Advisors increased its AstraZeneca (AZN) stake by 11% in Q2 2026, buying an estimated $2.07K and bringing the position to 114 shares worth $22K. The position accounts for 0.02% of the portfolio, ranked #300.

Pin Oak Investment Advisors first reported a position in AZN in Q4 2017 and has held it in 20 quarters since. The position peaked at $30K in Q1 2024. 1,507 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Pin Oak Investment Advisors held 114 shares of AstraZeneca worth $22K as of Q2 2026.
  • Pin Oak Investment Advisors bought 11 AstraZeneca shares in Q2 2026, an estimated $2.07K.
  • AstraZeneca made up 0.02% of Pin Oak Investment Advisors's portfolio in Q2 2026, its #300 holding.
  • Pin Oak Investment Advisors first reported a position in AstraZeneca in Q4 2017 and has held it in 20 quarters since.
  • Pin Oak Investment Advisors's AstraZeneca position peaked at $30K in Q1 2024.
  • 1,507 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Pin Oak Investment Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.